Did the Apyx Medical (APYX) Form 4 show any insider share sales or purchases?

The Form 4 shows only a grant of stock options to the COO and no open-market purchases or sales. The transaction is coded as a grant or award acquisition, reflecting compensation rather than trading activity in Apyx Medical shares.

Apyx Medical (NASDAQ: APYX) COO awarded stock options on 88,044 shares

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Apyx Medical Corp reported that Chief Operating Officer Shawn David Roman received a grant of stock options on Common Stock. The award covers 88,044 underlying shares with an exercise price of $4.65 per share and expires on June 11, 2036.

The options were granted as compensation and will vest ratably over 36 months, becoming fully vested and exercisable on the third anniversary of the grant date. Following this award, Roman holds 88,044 stock options directly, with no open-market share purchases or sales disclosed in this filing.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Roman Shawn David

Role Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Option to Buy)	88,044	$0.00	--

Holdings After Transaction: Stock Option (Option to Buy) — 88,044 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Option grant size: 88,044 shares Exercise price: $4.65 per share Expiration date: June 11, 2036 +2 more

5 metrics

Option grant size 88,044 shares Underlying common shares in new stock option award

Exercise price $4.65 per share Strike price of granted stock options

Expiration date June 11, 2036 Option term end date for the grant

Vesting period 36 months Options vest ratably and fully vest on third anniversary

Options held after grant 88,044 options Total stock options held by COO following this transaction

Key Terms

Stock Option (Option to Buy), exercise price, vesting, Common Stock

4 terms

Stock Option (Option to Buy) financial

"security_title: "Stock Option (Option to Buy)""

exercise price financial

"conversion_or_exercise_price: "4.6500""

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

vesting financial

"stock option which shall vest ratably over a thirty six (36) month period"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Common Stock financial

"underlying_security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

06/15/2026 - 07:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Roman Shawn David

(Last)

(First)

(Middle)

C/O APYX MEDICAL CORPORATION

5115 ULMERTON ROAD

(Street)

CLEARWATER

FLORIDA

33760

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Apyx Medical Corp [ APYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (Option to Buy)	$4.65	06/11/2026		A		88,044		⁽¹⁾	06/11/2036	Common Stock	88,044	$0	88,044	D

Explanation of Responses:

1. Reporting person was granted a stock option which shall vest ratably over a thirty six (36) month period and shall become fully vested and fully exercisable on the third anniversary of the date of grant.

	/s/ Shawn Roman	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Apyx Medical Corp (APYX) disclose in this Form 4 filing?

Apyx Medical Corp disclosed a stock option grant to its Chief Operating Officer, Shawn David Roman, covering 88,044 underlying common shares. The award is part of his compensation and does not involve any open-market stock purchases or sales.

How many Apyx Medical (APYX) shares are covered by the new stock option grant?

The stock option grant to COO Shawn David Roman covers 88,044 underlying shares of Apyx Medical common stock. These options give him the right to buy that number of shares at a fixed exercise price if he chooses to exercise them.

What is the exercise price and term of the APYX stock options granted to the COO?

The granted stock options have an exercise price of $4.65 per share and expire on June 11, 2036. This means the COO can buy shares at $4.65 any time after vesting until that expiration date, subject to award terms.

How do the COO’s Apyx Medical (APYX) stock options vest over time?

The stock options vest ratably over a 36‑month period and become fully vested and exercisable on the third anniversary of the grant date. This structure encourages long-term retention by tying full benefits to continued service at Apyx Medical.